Skip to main content
OpenTrials

Clinical trial condition

Substance Withdrawal Syndrome

Explore clinical trials studying Substance Withdrawal Syndrome. Study availability and eligibility vary by location and protocol.

60 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Substance Withdrawal Syndrome trial results

Completed

Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome

NCT00146471

Conditions
Alcohol Withdrawal Syndrome, Chemically-Induced Disorders, Mental Disorders, +2 more
Locations
  • MLU Halle-Wittenberg Halle, Sachen/Anhalt, Germany
  • Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Klinik für Psychiatrie und Psychotherapie Berlin, State of Berlin, Germany
  • Psychiatrische Klinik der Charité im St.-Hedwig Krankenhaus Berlin, State of Berlin, Germany
  • Klinik für Psychiatrie und Suchtmedizin, Kliniken Essen Mitte Essen, Germany
View Trial Details
Completed

Lofexidine for Inpatient Opiate Detox

NCT00235729

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations
  • CNS, Cerritos Cerritos, California, United States
  • CNS Psychiatric Institute of Washington Washington D.C., District of Columbia, United States
  • Atlanta Center for Medical Research Atlanta, Georgia, United States
  • Alexian Center for Psychiatric Research Hoffman Estates, Illinois, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Neurostimulation to Improve NOWS Outcomes

NCT05129020

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
Locations
  • Medical University of South Carolina - Shawn Jenkins Children's Hospital Charleston, South Carolina, United States
  • UT Southwestern Medical Center / Parkland Memorial Hospital Dallas, Texas, United States
  • University of Texas Health Science Center San Antonio San Antonio, Texas, United States
View Trial Details
Active, Not Recruiting

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia

NCT04147533

Conditions
Bone Marrow Diseases, Chemically-Induced Disorders, Chronic Disease, +17 more
Locations
  • University Hospital Brno Brno, Czechia
  • University Hospital Hradec Kralove Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Ostrava Ostrava, Czechia
View Trial Details

Related conditions